BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33914484)

  • 1. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 3. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
    Acharya SH; Avenell A; Philip S; Burr J; Bevan JS; Abraham P
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):943-50. PubMed ID: 18429949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves' disease.
    Donovan PJ; McLeod DS; Little R; Gordon L
    Eur J Endocrinol; 2016 Dec; 175(6):595-603. PubMed ID: 27634939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
    Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
    Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
    World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
    Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
    JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term monitoring of Graves’ disease in children and adolescents: a single-center experience.
    Tunç S; Köprülü Ö; Ortaç H; Nalbantoğlu Ö; Dizdarer C; Demir K; Özkan B
    Turk J Med Sci; 2019 Apr; 49(2):464-471. PubMed ID: 30862149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
    Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
    JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
    Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
    Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
    Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
    Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
    Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
    J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
    Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.